$ADPT Cashflow Statement | Understand Stock

$ADPT

$26.27 +$0.76 (2.98%) Close

$ADPT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense
Noncash lease expense
Share-based compensation expense
Intangible assets amortization
Investment amortization
Impairment of right-of-use and related long-lived assets
Impairment of long-lived assets
Research and development inventory reserve
Write-off of inventory
Revenue interest purchase agreement interest
Noncash interest expense
Other
Changes in operating assets and liabilities
Accounts receivable, net
Inventory
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
Operating lease right-of-use assets and liabilities
Deferred revenue
Other

Net cash used in operating activities
Investing activities
Purchases of property and equipment
Purchases of marketable securities
Proceeds from maturities of marketable securities
Net cash provided by investing activities
Financing activities
Proceeds from exercise of stock options
Proceeds from revenue interest purchase agreement, net of issuance costs
Proceeds from capital contributions for Digital Biotechnologies, Inc.
Cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Noncash investing activities
Purchases of equipment included in accounts payable and accrued liabilities
Supplemental disclosure of cash flow information
Cash paid for interest

Comments